IT1283945B1 - Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases - Google Patents
Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseasesInfo
- Publication number
- IT1283945B1 IT1283945B1 ITRM960136A IT1283945B1 IT 1283945 B1 IT1283945 B1 IT 1283945B1 IT RM960136 A ITRM960136 A IT RM960136A IT 1283945 B1 IT1283945 B1 IT 1283945B1
- Authority
- IT
- Italy
- Prior art keywords
- interferon
- natural human
- human alpha
- neoplasia
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 208000026278 immune system disease Diseases 0.000 title abstract 2
- 230000009826 neoplastic cell growth Effects 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 102000006992 Interferon-alpha Human genes 0.000 abstract 2
- 108010047761 Interferon-alpha Proteins 0.000 abstract 2
- 238000004113 cell culture Methods 0.000 abstract 2
- 210000004698 lymphocyte Anatomy 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
Abstract
The following are claimed: (A) use of natural human alpha -interferon for preparation of medicaments in liquid form, to be administered by the peroral route at dosages of 100-500 IU/day, for (i) therapy of viral hepatitis, or (ii) therapy of neoplasia and immunological diseases, in humans and animals; and (B) a pharmaceutical liquid composition for peroral administration, comprising natural human alpha -interferon (either from lymphoblastoid cell cultures or from lymphocyte cells) at a concentration of 100-500 IU/ml. The interferon is obtained from lymphoblastoid cell cultures or from lymphocyte cells. The medicament is administered in monodosage units of approximately 1 ml.
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM960136 IT1283945B1 (en) | 1996-02-28 | 1996-02-28 | Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases |
| DK97905395T DK0886527T3 (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical compositions containing natural human alpha interferon |
| PT97905395T PT886527E (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITION THAT INCORPORATES NATURAL HUMAN ALPHA INTERFERENCE |
| AU22299/97A AU722987B2 (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical compositions comprising natural human alpha-interferon |
| EP97905395A EP0886527B1 (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical compositions comprising natural human alpha-interferon |
| EA199800770A EA001147B1 (en) | 1996-02-28 | 1997-02-27 | Medicament for therapy of viral hepatitus |
| JP9530771A JP2000506839A (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical composition containing natural human α-interferon |
| KR10-1998-0706297A KR100394382B1 (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical composition consisting of natural human α-interferon |
| AT97905395T ATE205397T1 (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON |
| US09/125,122 US6884411B1 (en) | 1996-02-28 | 1997-02-27 | Method of treating viral hepatitis by administration of liquid human α-interferon |
| PCT/IT1997/000040 WO1997031649A1 (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON |
| BR9707772-0A BR9707772A (en) | 1996-02-28 | 1997-02-27 | Pharmaceutical compositions comprising natural human alpha-interferon |
| DE69706657T DE69706657T2 (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON |
| GEAP19974506A GEP20012489B (en) | 1996-02-28 | 1997-02-27 | Use of Natural Human α-Interferon |
| ES97905395T ES2160927T3 (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INTERFERED NATURAL HUMAN ALPHA. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM960136 IT1283945B1 (en) | 1996-02-28 | 1996-02-28 | Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM960136A0 ITRM960136A0 (en) | 1996-02-28 |
| ITRM960136A1 ITRM960136A1 (en) | 1997-08-28 |
| IT1283945B1 true IT1283945B1 (en) | 1998-05-07 |
Family
ID=11403951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM960136 IT1283945B1 (en) | 1996-02-28 | 1996-02-28 | Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1283945B1 (en) |
-
1996
- 1996-02-28 IT ITRM960136 patent/IT1283945B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITRM960136A1 (en) | 1997-08-28 |
| ITRM960136A0 (en) | 1996-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW265265B (en) | ||
| KR890700035A (en) | Improved Interferon Therapy | |
| AU7589587A (en) | Low dosage of interferon to enhance vaccine efficiency | |
| Borden et al. | Preclinical and clinical studies of interferons and interferon inducers in breast cancer | |
| IT1284852B1 (en) | Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases | |
| IT1283945B1 (en) | Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases | |
| HUP9902188A2 (en) | Pharmaceutical compositions comprising natural human alfa-interferon | |
| DE69706657T2 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING NATURAL HUMAN ALPHA INTERFERON | |
| OA08768A (en) | Treatment of AIDS virus with recombinant human alpha interferon. | |
| MY119359A (en) | Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. | |
| DE3686536D1 (en) | OXYTOCIN AND ANTI-DAYS TO INTRODUCE BIRTH. | |
| Sanders et al. | Immune-associated toxicities induced by in vivo and in vitro exposure to interferon-alpha alone or in combination with nucleoside analogs | |
| RU93041496A (en) | γ-PL / GAMMA-PLANT / -INTERFERINFORMING AGENT | |
| DK374388A (en) | IMMUNTERAPEUTIC, ORAL INTERFERONDOSIS FORM AND PROCEDURE FOR PREPARING IT | |
| RU92011195A (en) | METHOD FOR REDUCING THE DOSE OF CHEMICAL DRUGS USED TO TREAT INFECTIOUS DISEASES IN SIMULTANEOUSLY IMPROVING THEIR THERAPEUTIC EFFICIENCY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |